[Xuebijing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial: research results and clinical value].
This article is based on the research paper named Xuebijing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial which was published in Critical Care Medicine (CCM), introducing its study results and relevant clinical value. Moreover, we attached two peer experts' comments on this study for the readers' reference.